Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer

Keyphrases

• Estrogen Receptor β 100%
• Triple-negative Breast Cancer 100%
• Proliferation Migration 42%
• Triple-negative Breast Cancer Cells 42%
• Breast Tumor 28%
• Breast Cancer Cell Lines 28%
• Survivin 28%
• Small Interfering RNA (siRNA) 14%
• Gene Expression 14%
• Specific Genes 14%
• Breast Cancer 14%
• Cell Proliferation 14%
• Targeted Therapy 14%
• E-cadherin 14%
• Cell Activity 14%
• Knockdown 14%
• Clinical Outcomes 14%
• Therapeutic Target 14%
• Breast Cancer Cells 14%
• Ligand-dependent 14%
• Oncogene 14%
• Absolute Amount 14%
• Cell Migration 14%
• Relative Ratio 14%
• Tumor Suppressor 14%
• Cell Invasion 14%
• Outcome Prediction 14%
• Expression Effects 14%
• Ligand-independent 14%
• Endogenous Formation 14%
• Endocrine Therapy 14%
• Cystatin 14%
• Invasion Genes 14%
• Aggressive Subtypes 14%
• Doxycycline-inducible 14%
• Prognostic Relevance 14%
• Therapeutic Relevance 14%
• Breast Cancer Subtypes 14%
• Lentiviral System 14%
• Outcome Therapy 14%
• Survivin Expression 14%
• Prognostic Effect 14%

Biochemistry, Genetics and Molecular Biology

• Isoform 100%
• Estrogen Receptor Beta 100%
• Cancer Cell 42%
• Survivin 42%
• Upregulation 28%
• Small Interfering RNA 14%
• Gene Expression 14%
• Cadherin 14%
• Cell Migration 14%
• Messenger RNA 14%
• Cell Proliferation 14%
• Proto Oncogene 14%
• Cell Activity 14%
• Tumor Suppressor Protein 14%
• Cell Invasion 14%
• Cystatin 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Estrogen Receptor Beta 100%
• Triple Negative Breast Cancer 100%
• Survivin 42%
• Breast Cancer 28%
• Small Interfering RNA 14%
• Neoplasm 14%
• Breast Tumor 14%
• Uvomorulin 14%
• Doxycycline 14%
• Tumor Suppressor Protein 14%
• Endocrine Therapy 14%
• Isoprotein 14%
• RNA Isoform 14%
• Cystatin 14%